MyMD Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Share-based Payments (Tables)

Share-based Payments (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation Warrants Activity

					Weighted
					Average
			Weighted		Remaining		Aggregate
	Number of		Average		Contractual		Intrinsic
	Shares		Exercise Price		Term (years)		Value
*Balance at December 31, 2013*		1,989	$	71.76
Granted		-		-
Exercised		-		-
Forfeited		-		-
Canceled/Expired		-		-
*Balance at December 31, 2014*		1,989	$	71.76
*Exercisable as of December 31, 2014*		1,989	$	71.76		0.21	$	-

Schedule of Fair Value of Options Under Expense Category

The calculated fair value of these options was distributed to the following categories on the consolidated statement of operations and comprehensive loss:

Expense Category	2014		2013
Cost of Goods	$	24,040	$	-
General & Administrative		357,276		-
Sales & Marketing		48,081		-
Research & Development		120,203		-
	$	549,600	$	-

Schedule of Options And Warrants Valuation Assumptions Under Black Scholes Pricing Model

The options and warrants issued under the above four plans were valued using a Black Scholes option pricing model. The assumptions utilized in calculating the value of the issued options under Black Scholes are as follows:

	2014			2013
Expected option term		5 yrs			n/a
Expected volatility		127.32	%		n/a
Expected divident yeild		0.00	%		n/a
Risk free interest rate		1.71	%		n/a

Summary of Stock Options Activity

The following table summarizes the option activities for the year ended December 31, 2014:

					Average
			Weighted		Remaining		Aggregate
	Number of		Average		Contractual		Intrinsic
	Shares		Exercise Price		Term (years)		Value
*Balance at December 31, 2013*		-	$	-
Granted		175,000		4.98
Exercised		-		-
Forfeited		-		-
Canceled/Expired		-		-
*Balance at December 31, 2014*		175,000	$	4.98
*Exercisable as of December 31, 2014*		175,000	$	4.98		4.50	$	600

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details